Literature DB >> 180033

An analysis of lectin-initiated cell agglutination in a series of CHO subclones which respond morphologically to growth in dibutyryl cyclic AMP.

J van Veen, R M Roberts, K D Noonan.   

Abstract

We have investigated the molecular basis of the agglutinability of CHO subclones which respond differentially in terms of morphology and surface architecture in the presence of dB-cAMP in the medium. We have demonstrated that the agglutinability of these subclones with both wheat germ agglutinin (WGA) and concanavalin A (Con A) probably depends on the free lateral mobility of the lectin receptor sites in the plane of the membrane. The nonagglutinable surface architecture seems to depend on the presence in the membrane of a protease-labile peptide(s), which appears to be distinct from the lectin receptors, as well as on continuous protein and RNA synthesis. This dependence on continuous transcription and translation may be related to the maintenance of the protease-labile peptide(s) in such a state as to restrict mobility of the lectin receptors. The surface architecture defined as nonagglutinable also depends on the state of polymerization of the intracellular microtubules and microfilaments. It is suggested that these microskeletal elements serve to anchor the lectin receptors in such a manner as to restrict their mobility and thereby reduce the relative agglutinability of a cell line. We suggest that control of the free mobility of both the Con A and WGA receptor sites is dependent on two constraints, one applied by protease-labile ("surface") membrane components and the other by components of the intracellular microskeletal system.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 180033      PMCID: PMC2109801          DOI: 10.1083/jcb.70.1.204

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  30 in total

1.  Cyclic AMP modulates microvillus formation and agglutinability in transformed and normal mouse fibroblasts.

Authors:  M C Willingham; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

2.  A comparative study of glycoproteins from the surface of control and Rous sarcoma virus transformed hamster cells.

Authors:  C A Buck; M C Glick; L Warren
Journal:  Biochemistry       Date:  1970-11-10       Impact factor: 3.162

3.  Temperature-dependent mobility of concanavalin A sites on tumour cell surfaces.

Authors:  G L Nicolson
Journal:  Nat New Biol       Date:  1973-06-13

4.  Surface-specific characteristics of a contact-inhibited cell line containing the SV40 viral genome.

Authors:  R E Pollack; M M Burger
Journal:  Proc Natl Acad Sci U S A       Date:  1969-04       Impact factor: 11.205

5.  A difference in the architecture of the surface membrane of normal and virally transformed cells.

Authors:  M M Burger
Journal:  Proc Natl Acad Sci U S A       Date:  1969-03       Impact factor: 11.205

6.  Inhibition of lectin agglutinability by fixation of the cell surface membrane.

Authors:  M Inbar; C Huet; A R Oseroff; H Ben-Bassat; L Sachs
Journal:  Biochim Biophys Acta       Date:  1973-07-18

7.  Cytochalasin B: lack of effect on mucopolysaccharide synthesis and selective alterations in precursor uptake.

Authors:  R H Cohn; S D Banerjee; E R Shelton; M R Bernfield
Journal:  Proc Natl Acad Sci U S A       Date:  1972-10       Impact factor: 11.205

8.  The relationship of concanavalin A binding to lectin-initiated cell agglutination.

Authors:  K D Noonan; M M Burger
Journal:  J Cell Biol       Date:  1973-10       Impact factor: 10.539

9.  Intramembrane particle aggregation in erythrocyte ghosts. I. The effects of protein removal.

Authors:  A Elgsaeter; D Branton
Journal:  J Cell Biol       Date:  1974-12       Impact factor: 10.539

10.  Effects of colchicine, cytochalasin B, and 2-deoxyglucose on the topographical organization of surface-bound concanavalin A in normal and transformed fibroblasts.

Authors:  T E Ukena; J Z Borysenko; M J Karnovsky; R D Berlin
Journal:  J Cell Biol       Date:  1974-04       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.